Mohamed Magdy

- Achieved Guinness World Record for Novartis Oncology with the Largest Aluminium Sculpture with 25.3 ft . Ask me WHY and HOW!
- Won Emerging Growth Market (EGM) Innovation Award, Novartis Oncology, May 2017.
- Won Global Marketing Best Practice 1st Place Winner Award at "PULSE"​ Programme, Novartis Oncology, Sept. 2015.
- Won "Performance"​ Award in Novartis Oncology for Driving Solid Tumors Brand Performance and deliverables in 2016.

- Currently responsible for Breast Cancer Portfolio (Afinitor, Tykerb and new launches): effective from Jan 2017 - till present.
- Was responsible for 3 Products in Breast Cancer, Renal Cell Carcinoma and Soft Tissue Sarcoma Disease Areas in Saudi Arabia; Afinitor (BC and RCC), Tykerb (BC), and Votrient (RCC/STS) from June 2015- Dec 2016.

- Selected in Emerging Growth Market (EGM) Taskforces for AFINITOR, TYKERB, and EGM Digital Ambassadors. Also, assigned to lead Digital Marketing in Saudi Arabia for Oncology and Hematology Franchises, since May 2016 till present.

Was responsible for preparing the launch campaign of Respiratory new launch "RELVAR" including the the internal and external launch campaign, inclusion file, eDetailers, and others.

Responsible for Allergy Portfolio in GSK Saudi.

Selected Tactical and Strategic Accomplishments
• led ATC4 Allergy constructed market (ANH+INS) with 8.8$M, value MS 11.3%, GR by 26% and EI 118, YTD Dec. 14
• Earned 6% Value MS in INS Portfolio results in no. 1 ranked INS Position, GR by 34%, EI 126, 6.2 $M and leading INS Rx by 19%MS for Avamys (YTD Dec. 14).
• Won the 1st Place in GSK MENA/CIS as Best Practice in Captivator! - Jul 14.
• Launched Got-to-Know Pharmacy Campaign; recognized as Best Practice in CTC excellence MENA/CIS - Oct.14.
• Won the Best Marketing Exhibition in GSK Saudi POA - Sep.14.
• Nominated as MODCF Champion to improve the forecast accuracy in GSK Saudi up to 70% - Mar14.
• Earned the National Best Achiever Award at GlaxoSmithKline Thrice for boosting sales in 2013, 2012, and 2011 years by $1.5M, $2.9M, and $ 2.2M resulting in 105%, 133%, and 115% increase in revenues for Oncology and Respiratory Portfolios in GSK.
• Launched the 1st Mobile App for Patients and Mobile Game for HCPs in GSK Saudi Arabia.

Responsible for three Oncology & Hematology Products: Tykerb (Lapatinib), Votrient (Pazopanib), and Revolade (Eltrombopag) for treatment of Breast Cancer, Renal Cell Carcinoma, and Immune Thrombocytopenia in the Eastern Province of Saudi Arabia.

• Earned GSK Ambassador award for being a role model in Quality Achievements for 2012.

• In three years time-frame, made triple digit growth (200%) in boosting SERETIDE 250 Diskus sales in ARAMCO from 8, 140 to 24, 000 Units that accomplishing 3.9M SR in 2012

Selected Accomplishment:
Earned the Best Achiever Award at GlaxoSmithKline; for boosting sales in one year time by $ 2.2M resulting in a 115% increase in revenues. - Ask Me How

Selected Accomplishment:
Managed two teams of sales representatives promoting 7 (seven) problematic company products; yet grew sales by 30%; accomplishing a $ 300, 000 sales increase in a 6 (six) month time frame. - Ask Me How

Selected Accomplishment:
In one years’ time while employed at Schering-Plough, improved sales revenue by $ 408, 000 representing a 27% increase over the previous year. - Ask me How